• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

    7/24/24 4:00:04 PM ET
    $FOXO
    Life Insurance
    Finance
    Get the next $FOXO alert in real time by email
    SC 13D/A 1 ea020988405-13da2white_foxo.htm AMENDMENT NO. 2 TO SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION,
    Washington, D.C. 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

    FOXO Technologies Inc.
    (Name of Issuer)

     

    Class A Common stock, par value $0.0001 per share
    (Title of Class of Securities)

     

    351471305
    (CUSIP Number)

     

    Mark Brian White

    9 King George V Place

    Winchester, UK SO22 SFU

    44 7973 802488

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    July 22, 2024
    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     
    CUSIP No. 351471305
    (1)

    Names of reporting persons

     

      Mark Brian White
    (2) Check the appropriate box if a member of a group (see instructions)
      (a) ☐
      (b) ☐
    (3)

    SEC use only

     

       
    (4)

    Source of funds (see instructions)

     

     
    (5)

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

       
    (6)

    Citizenship or place of organization

     

      United Kingdom

    Number of
    shares
    beneficially
    owned
    by each
    reporting
    person
    with:
    (7)

    Sole voting power

     

    (8)

    Shared voting power

     

    0 (1)

    (9)

    Sole dispositive power

     

    (10)

    Shared dispositive power

     

    0 (1)

    (11)

    Aggregate amount beneficially owned by each reporting person

     

      0 (1)
    (12)

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

      ☐
    (13)

    Percent of class represented by amount in Row (11)

     

      0 (1)
    (14)

    Type of reporting person (see instructions)

     

      IN

     

    (1)Gives no effect to shares which may be issued to Kr8 ai Inc., of which the Reporting Person is an officer, director and shareholder as consideration for rights granted and services to be rendered pursuant to the Master Software and Services Agreement between Kr8 ai Inc. and the Issuer. The terms of the Master Software and Services Agreement provide for the issuance of additional shares to Kr8 ai Inc. on terms and conditions set forth therein.

     

    2

     

    ITEM 1. SECURITY AND ISSUER.

     

    This Amendment No. 2 to the Statement of Beneficial Ownership filed on February 2, 2024 (the “Statement”), relates to the Class A common stock of FOXO Technologies Inc. (“Issuer”) and is being filed to reflect the fact that on July 22, 2024, in a private transaction, KR8 ai Inc. transferred 1,300,000 shares of the Class A common stock of the Issuer.

     

    ITEM 2. IDENTITY AND BACKGROUND.

     

    The information set forth in Item 2 of the Statement is incorporated herein by reference in response to the requirements of Item 2 of Schedule 13D.  

     

    ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     

    Not applicable.

     

    ITEM 4. PURPOSE OF TRANSACTION.

     

    Not applicable.

     

    ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

     

      (a) See rows (11) and (13) of the cover page to this Statement for the aggregate number of shares of Class A common stock and percentage of Class A common stock of the Issuer owned by the Reporting Person as of the date hereof.

     

      (b) See rows (7) through (10) of the cover page to this Amendment for the number of shares of Class A common stock as to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition as of the date hereof.

     

      (c) During the past sixty days, except for the sale of the shares reported in this Amendment, the Reporting Person has not effected any transactions in the Issuer’s Common Stock.

     

      (d) To the best knowledge of the Reporting Person, except as to the securities owned by Kr8 ai Inc., no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Person.

     

      (e) Not applicable.

     

    ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

     

    The information set forth in Item 6 of the Statement is incorporated herein by reference in response to the requirements of Item 6 of Schedule 13D.

     

    ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.

     

    Not applicable.

     

    3

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      Date July 23, 2024
         
      Signature /s/ Mark Brian White
      Name/Title    Mark Brian White

     

     

    4

     

     

     

     

     

    Get the next $FOXO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FOXO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FOXO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FOXO TECHNOLOGIES INC.'S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES

      WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. Since operations commenced at its Oneida, Tennessee location in August 2023, the facility has seen over 400 patients and has served patients for over 5,000 care days. Robert Merritt, Chief of Executive Officer of Myrtle stated, "We are excited about reaching these important patient care milestones as they are indicative of the strong presence and reputation our facility has for delivering exemplary care for substance use disorder patients in East

      5/6/25 8:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

      West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company"), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the "Effective Time"), the Company completed a 1 for 10 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on Tuesday April 29, 2025, on a post-split basis and continue to trade under the symbol FOXO. As a result of the reverse split, every 10 shares of the Company's common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share with no change in the nominal par value per share of $0.0001. No fractional

      4/29/25 10:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT

      FLORIDA, April 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company"), today announced that its Board of Directors has approved a 1 for 10 reverse stock split of the Company's Class A common stock, par value $0.0001 (the "Common Stock"). The reverse stock split will become effective at 4:01pm ET on April 28, 2025 (the "Effective Time"). The Common Stock will begin trading on a split-adjusted basis on the NYSE American under the same trading symbol "FOXO" when the market opens on April 29, 2025, and will trade under a new CUSIP number. The reverse stock split was approved by the Company's stockholders at the Company's Annual Meeting, held on November 29,

      4/17/25 5:00:00 PM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by FOXO Technologies Inc.

      SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      11/7/24 8:46:01 AM ET
      $FOXO
      Life Insurance
      Finance
    • Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

      SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      9/23/24 4:15:07 PM ET
      $FOXO
      Life Insurance
      Finance
    • SEC Form SC 13D filed by FOXO Technologies Inc.

      SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      8/5/24 4:15:29 PM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Langley Trevor claimed ownership of 1,023,629 shares (SEC Form 3)

      3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      9/12/24 5:28:21 PM ET
      $FOXO
      Life Insurance
      Finance
    • New insider Lagan Seamus claimed ownership of 1,023,629 shares (SEC Form 3)

      3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      9/12/24 5:27:29 PM ET
      $FOXO
      Life Insurance
      Finance
    • Large owner Kr8 Ai Inc. sold $325,000 worth of shares (1,300,000 units at $0.25), closing all direct ownership in the company (SEC Form 4)

      4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      7/24/24 4:00:23 PM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Financials

    Live finance-specific insights

    See more
    • FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY

      MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond. Dear Fellow Shareholders, Our recent shareholders meeting on January 17th concluded the requirements of 2024 acquisition agreements and resulted in a change of control of the Company. The accomplishments in the second half of 2024 have been key to what we believe is becoming a very successful turnaround of our Company and has created a foundation from which we believe we can build a significant and profitable

      1/28/25 8:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR

      MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO"), provides a shareholder letter from Mark White, Interim CEO of FOXO, on what has been achieved in 2024 and what is planned for the remainder of 2024 and beyond. Dear Fellow Shareholders, 2024 has been an exciting, tumultuous and productive year for us. We believe the accomplishments already completed and that we believe will be achieved before year-end create a foundation from which we can build a successful enterprise that will increase shareholder value. The Company began 2024 with a continued focus on commercializing its epigenetic technology while, at the same ti

      10/15/24 8:30:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc.

      MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), today announced it has completed the acquisition of the second revenue-generating operation from Rennova Health, Inc. (OTC:RNVA) ("Rennova").  The Company had previously announced it had entered into two share exchange agreements with Rennova. The first agreement was to acquire the equity in Myrtle Recovery Centers, Inc., Rennova's behavioral health services subsidiary. Closing of the Myrtle transaction occurred on June 14, 2024. The second agreement was to acquire the equity in Rennova Community Health, Inc. (RCHI), the owner of Scott County Community Hospital, I

      9/17/24 9:00:00 AM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    SEC Filings

    See more
    • SEC Form EFFECT filed by FOXO Technologies Inc.

      EFFECT - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/7/25 12:15:15 AM ET
      $FOXO
      Life Insurance
      Finance
    • SEC Form 424B4 filed by FOXO Technologies Inc.

      424B4 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/6/25 4:51:42 PM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/6/25 4:05:27 PM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Leadership Updates

    Live Leadership Updates

    See more
    • FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER

      MINNEAPOLIS, MN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO") announces a series of restructuring and capital raising transactions which will improve the Company's balance sheet, satisfy minimum stockholders' equity requirements of the NYSE American and provide capital for growth and reduce outstanding liabilities. The Company also announces a change in senior leadership. Key transactions include: Rennova Health, Inc.'s exchange of approximately $21 million of a Senior Secured Note issued by Rennova Community Health, Inc., the Company's subsidiary, into 21,000 shares of the Company's Series A Cumulative Convertible Redeemable Pr

      12/11/24 8:00:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors

      FOXO Technologies Inc. (NYSE:FOXO) (the "Company"), today announced the appointment of Francis Colt deWolf to the Company's Board of Directors. Mr. deWolf III brings over 20 years of experience in the financial services Sector. He currently serves as President of Colt Capital LLC, a Florida-based company, whose principal activities focus on advising emerging market companies on private and public financing strategies. Prior to founding Colt Capital LLC, Mr. deWolf was a Senior Vice President at Oppenheimer and Company, where he oversaw a variety of financing activities. Mr. deWolf also served as Vice President at Prudential Securities and as a bond broker for Tucker Anthony. Mr. deWolf is

      1/25/24 5:00:00 PM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO Technologies™ Announces Resignation of Taylor Fay, Chief Operating Officer

      FOXO Technologies Inc. (NYSEAM:FOXO), a leader in commercializing epigenetic biomarkers of health and aging, today announced the resignation of Taylor Fay as Chief Operating Officer of the Company, effective April 28, 2023. "I am extremely proud of our achievements throughout Taylor's tenure at FOXO," said Tyler Danielson, interim CEO, and Chief Technology Officer at FOXO. "His leadership and work ethic inspired those around him, and we are a more talented and dedicated team because of his contributions. The Board and executive leadership thank Taylor for his leadership and wish him well in his future endeavors." "Throughout my tenure at FOXO, I have worked alongside an exceptional team

      4/18/23 8:00:00 AM ET
      $FOXO
      Life Insurance
      Finance